Additional information
| Active substance | Anastrozole |
|---|---|
| Active Half-Life | 2 days |
| Classification | Non-steroidal aromatase inhibitor |
| Dosage | 0.5-1 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | NO |
| Aromatization | No |
| Lab Test | See Document |
| Also known as | Anastrozol |
| WAREHOUSE | USA Warehouse 3 |
| Blood pressure | Can sometimes lower blood pressure due to reduced estrogen levels |
| Trade name | Arimidex |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropiononitrile) |
| Formula | C17H19N5 |
| Substance class | Aromatase inhibitor |
| Main action | Inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens |
| Half-life | Approximately 50 hours |
| Dosage (medical) | Typically 1 mg per day |
| Dosage (sports) | Not commonly prescribed for sports uses, but dosages in unofficial contexts can vary |
| Effects | Reduces estrogen levels, useful in the treatment of estrogen receptor-positive breast cancer |
| Side effects | Hot flashes, joint symptoms, weakness, mood changes, bone loss, increased risk of osteoporosis |
| Use in sports | Sometimes used by bodybuilders to reduce the effects of estrogen related to the use of anabolic steroids |
| Manufacturer | Euro-Pharmacies – US |
Reviews
There are no reviews yet.